Essential hypertension and insulin resistance. 1991

R Dzúrik, and J Málková, and V Spustová
Centre of Clinical Pharmacology, Institute of Preventive and Clinical Medicine, Bratislava, Czechoslovakia.

Insulin resistance (IR) appears to be an important risk factor of both hypertension and atherosclerosis. Moreover, it is present also in obesity, dyslipoproteinaemia and non-insulin dependent diabetes. IR could be found in untreated hypertension and even in normotensive children of hypertensive parents. It alters carbohydrate, lipid and protein metabolism and participates directly in the development of hypertension. The diagnosis of IR is possible by simple determination of insulin and glyceamia during glucose tolerance test. The differential diagnosis is obligatory because IR is not specific just for hypertension. Treatment, with the exception of nonpharmacological measures, is unsatisfactory. However, results of newest research are highly promising.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

R Dzúrik, and J Málková, and V Spustová
January 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
R Dzúrik, and J Málková, and V Spustová
August 1987, The New England journal of medicine,
R Dzúrik, and J Málková, and V Spustová
January 1992, Hormone research,
R Dzúrik, and J Málková, and V Spustová
June 2000, Journal of hypertension,
R Dzúrik, and J Málková, and V Spustová
December 1997, Hypertension (Dallas, Tex. : 1979),
R Dzúrik, and J Málková, and V Spustová
May 1994, Casopis lekaru ceskych,
R Dzúrik, and J Málková, and V Spustová
April 1991, American heart journal,
R Dzúrik, and J Málková, and V Spustová
December 1989, European journal of clinical investigation,
R Dzúrik, and J Málková, and V Spustová
August 1997, Archives des maladies du coeur et des vaisseaux,
R Dzúrik, and J Málková, and V Spustová
October 1998, International journal of cardiology,
Copied contents to your clipboard!